New Cape: At present, the company's revenue from AI products is not high. The new Cape said on the interactive platform on December 12 that the company actively explored in the field of artificial intelligence and gradually established its own AI corpus to support the research and development of intelligent services and products. At present, the company's AI product revenue is not high, which will not have a significant impact on the company's performance.China Chengtong and China Yizhong set up an enterprise management center with a capital contribution of 6.25 billion yuan. According to Tianyancha App, Zhongcheng (Beijing) Enterprise Management Center (Limited Partnership) was recently established. The executive partner is Yizhong Group Sunac Technology Development Co., Ltd., with a capital contribution of 6.25 billion yuan. The business scope is enterprise management and enterprise management consulting. It is owned by China Chengtong's Beijing Chengtong Capital Investment Co., Ltd., China Yizhong Group Co., Ltd. and its subsidiary Sunac Technology Development Co., Ltd.China Chengtong and China Yizhong set up an enterprise management center with a capital contribution of 6.25 billion yuan. According to Tianyancha App, Zhongcheng (Beijing) Enterprise Management Center (Limited Partnership) was recently established. The executive partner is Yizhong Group Sunac Technology Development Co., Ltd., with a capital contribution of 6.25 billion yuan. The business scope is enterprise management and enterprise management consulting. It is owned by China Chengtong's Beijing Chengtong Capital Investment Co., Ltd., China Yizhong Group Co., Ltd. and its subsidiary Sunac Technology Development Co., Ltd.
ECB: Financing conditions are relaxing, ECB: Financing conditions are relaxing. However, because monetary policy is still restrictive and past interest rate hikes are still being transmitted to the credit stock, financing conditions are still tightening. Inflation prospect, core inflation and its transmission will determine the interest rate path.Blinken arrived in Jordan to attend an emergency meeting on Syria. It is reported that US Secretary of State Blinken arrived in Jordan on Thursday to attend an emergency meeting on Syria. Blinken will meet with Jordanian Foreign Minister Assafadi and King Abdullah.Traders' interest rate expectations for the European Central Bank remain stable: it is expected to cut interest rates by 127 basis points in 2025.
Volkswagen's board of directors tends not to close large German factories, and Volkswagen's board of supervisors tends not to close large German factories to cope with the cost crisis of the automaker, but no final agreement has been reached. It is reported that members of the board of directors discussed stopping the production of the Dresden factory and selling the Osnabrü ck factory.The legal representative of Sanzhiyang Culture Media Co., Ltd. changed. Tianyancha App showed that on December 10, Hefei Sanzhiyang Culture Media Co., Ltd. changed its business. Ba Shuai stepped down as the legal representative, executive director and general manager, and Zhang Yong was the legal representative, director and manager. The company was established in May 2022 with a registered capital of RMB 1 million. Its business scope includes radio and television program production and operation, performance brokerage, advertising, organization of cultural and artistic exchange activities, conference and exhibition services, etc. It is wholly owned by Hefei Sanzhiyang Network Technology Co., Ltd.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).
Strategy guide
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14